| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.63 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |